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Abstract: Using Micro-Electro-Mechanical-Systems (MEMS) technologies, we have 
developed silicon wafer-based platinum microelectrode arrays (MEAs) modified with 
glutamate oxidase (GluOx) for electroenzymatic detection of glutamate in vivo. These 
MEAs were designed to have optimal spatial resolution for in vivo recordings. Selective 
detection of glutamate in the presence of the electroactive interferents, dopamine and 
ascorbic acid, was attained by deposition of polypyrrole and Nafion. The sensors 
responded to glutamate with a limit of detection under 1µM and a sub-1-second response 
time in solution. In addition to extensive in vitro characterization, the utility of these MEA 
glutamate biosensors was also established in vivo. In the anesthetized rat, these MEA 
glutamate biosensors were used for detection of cortically-evoked glutamate release in the 
ventral striatum. The MEA biosensors also were applied to the detection of stress-induced 
glutamate release in the dorsal striatum of the freely-moving rat. 
 
Keywords: Glutamate Biosensor; Constant Potential Amperometry; Nafion; Polypyrrole; 
Central Nervous System. 
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1. Introduction  
 
The amino acid L-glutamate (glutamate) is the major excitatory neurotransmitter in the mammalian 
central nervous system and as such underlies not only normal, but also many abnormal behaviors 
apparent in neurological and psychiatric disorders [1-5]. Therefore, a tool for measuring glutamatergic 
transmission in a behaviorally relevant manner will greatly aid our understanding of these processes.  
A variety of sampling methods for the measurement of extracellular brain chemicals, including 
glutamate, are available. One commonly used method, microdialysis coupled with high performance 
liquid chromatography, allows for the selective measurement of many different neuromodulators. 
Unfortunately, even advanced microdialysis techniques do not offer the temporal resolution required 
for sophisticated behavioral studies [6]. Behavior, especially motivated behavior, can change within 
seconds of stimuli presentation [7], and the 5-10 min temporal resolution of microdialysis [6] time-
averages these fast changes [7-10]. Electrochemical sensors used with voltammetric recording 
techniques offer an alternative method for measurement of electroactive neurotransmitters, such as 
dopamine (DA), with improved temporal and spatial resolution [10]. The non-electroactive nature of 
glutamate poses difficulties to its sensitive and selective measurement with such techniques. 
Fortunately, implantable biosensors, analytical tools consisting of both a biochemical recognition 
element and a physical transducer, circumvent these obstacles.  
Amperometric electroenzymatic methods for the near real-time detection of glutamate have been 
developed using platinum electrodes modified with glutamate oxidase (GluOx) [11-13]. GluOx is a 
flavoenzyme that catalyzes the oxidative deamination of glutamate in the presence of water and 
oxygen with the formation of α-ketoglutarate, ammonia and hydrogen peroxide (H2O2) [14]. 
Electrooxidation of the enzymatically generated H2O2 allows for effective glutamate detection [11]. 
Unfortunately, efficient oxidation of H2O2 requires a high anodic potential at which electroactive 
interferents, such as DA and ascorbic acid (AA), are also oxidized and thereby contribute an undesired 
amperometric current signal [15]. Several approaches have been taken to eliminate electroactive 
interference, such as immobilization of ascorbate oxidase [16], coating with permselective polymers 
[15-17], self-referencing [18] and co-immobilization of peroxidase with a redox polymer [19].  
In addition to electroactive interference exclusion and temporal resolution, precise spatial 
resolution is also important to permit measurement of glutamate from discrete brain regions in vivo. 
Glutamate can play differing roles in behavior based on the specific brain region or even subregion in 
which it is released [20], therefore an optimal biosensor for glutamate would be able to make 
glutamate recordings from a population of cells within a single brain subregion. Previously, we and 
others described effective platinum wire-based electrodes for amperometric detection of  
glutamate [13, 15]. However, the signal-to-noise characteristics and required exposed surface of these 
electrodes make them sub-optimal for spatially precise glutamate measurements in vivo. More 
recently, we adapted an over-oxidized polypyrrole coating approach to commercially available ceramic 
MEAs developed by Gerhardt and colleagues (Quanteon, LLC). Here, we describe the fabrication of 
significantly smaller, silicon wafer-based microelectrode array (MEA) probes coated with both Nafion 
and polypyrrole (PPy), which reduce signal from the interferents, AA and DA, respectively, to below 
baseline noise levels while maintaining the fast response time necessary for temporally precise 
measurements of glutamate in vivo. These silicon wafer-based glutamate biosensors have been tested 
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extensively in vitro and have been applied to measurement of cortical electrical stimulation- and 
behaviorally-evoked glutamate release in vivo.  
 
2. Experimental Section  
 
2.1. Reagents 
 
Nafion (5 wt.% solution in lower aliphatic alcohols/H2O mix), bovine serum albumin (BSA, min 
96%), glutaraldehyde (25% in water), pyrrole (98%), L-glutamic acid, L-ascorbic acid, 3-hydroxy-
tyramine (dopamine) were purchased from Aldrich Chemical Co. (Milwaukee, WI, USA). GluOx from 
Streptomyces Sp. X119-6, with a rated activity of 24.9 units per mg protein (U mg-1, Lowry’s method), 
produced by Yamasa Corporation (Chiba, Japan), was purchased from Associates of Cape Cod, Inc. 
(Seikagaku America, MA, USA). Phosphate buffered saline (PBS) was composed of 50 mM Na2HPO4 
with 100 mM NaCl (pH 7.4). Ultrapure water generated using a Millipore Milli-Q Water System was 
used for preparation of all solutions used in this work. 
 
2.2. Instrumentation  
 
Electrochemical preparation of the sensors was performed using a Versatile Multichannel 
Potentiostat (model VMP3) equipped with the ‘p’ low current option and low current N’ stat box (Bio-
Logic USA, LLC, Knoxville, TN, USA). In vitro and in vivo experiments were conducted with a 
multichannel FAST-16 potentiostat (Quanteon, LLC, Lexington, KY, USA). Electropolymerization of 
PPy was conducted using a standard three-electrode system, consisting of a platinum wire auxiliary 
electrode, a glass encased Ag/AgCl in 3M NaCl solution reference electrode (Bioanalytical Systems, 
Inc., West Lafayette, IN, USA), and a platinum working electrode on our MEA probes. In vitro and in 
vivo measurements were conducted using a two-electrode system, with reference electrodes consisting 
of a glass-enclosed Ag/AgCl wire in 3 M NaCl solution (Bioanalytical Systems, Inc., West Lafayette, 
IN, USA) or a 200 µm diameter Ag/AgCl wire, respectively. All potentials are reported versus the 
Ag/AgCl reference electrode. 
 
2.3. Electrode Fabrication and Polymer Modification 
 
The MEA probes were fabricated at the Nanoelectronics Research Facility at UCLA. A 1 µm thick 
layer of silicon dioxide was grown thermally on a thin (150 µm) silicon substrate (Figure 1A). The 
thermal oxide is a high quality dielectric film that electrically isolates the substrate from the metal 
layer subsequently deposited. Electron-beam evaporation was used to deposit 1000 Å of platinum on a 
200 Å chromium adhesion layer. The metal was patterned by photolithography and lift-off to define 
the bonding pads, connections, and electrode sites (Figure 1B). Next, plasma enhanced chemical vapor 
deposition (PECVD) was used to deposit a 1 µm layer of silicon dioxide (Figure 1C). This second 
dielectric layer chemically isolates the connections from solution during electrochemical testing. After 
patterning of the oxide layer with a conventional photolithographic technique, the contact pads and 
electrode sites were plasma etched by reactive ion etching (RIE) (Figure 1D). A third 
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photolithographic treatment was performed to pattern the outline of the probes. RIE was then used to 
etch through the first and second dielectric layers, and deep reactive ion etching (DRIE) by the Bosch 
process was used to etch through the silicon substrate (Figure 1E).  
 
Figure 1. Fabrication process flow diagram of silicon wafer-based MEA probe (cross-
section view) (a) 1µm SiO2 was grown thermally on a 150-µm Si wafer. (b) Cr and Pt were 
deposited by e-beam evaporation followed by a lift-off process to form the electrodes and 
connections. (c) SiO2 (1 µm) was deposited as the insulating layer by PECVD. (d) The 
SiO2 passivation layer was plasma-etched by RIE at the electrode sites and contact pads. 
(e) A sequential RIE and DRIE through-wafer etch was done to release the probes. 
 
After the MEA probes were individually released from the wafer they were packaged and 
chemically cleaned to prepare the electrode surfaces for chemical modification with polymers and 
enzyme. Packaging involved soldering 28-gauge wire to the platinum bonding pads at the top of the 
MEA. Each MEA was cleaned with a 1:4 H2O2:H2SO4 solution. The tip of the MEA was lowered into 
the cleaning solution for 3 min and then rinsed with stirred purified H2O for 3 min; this process was 
repeated 3 times. Following cleaning, the electrodes were dried with argon. Each electrode was coated 
with PPy and Nafion. PPy was electrodeposited by holding the voltage constant at 0.85 V for 2.5–5 
min until a total charge density of 20 mC/cm2 was reached in a 200 mM argon-purged solution of 
pyrrole in PBS at pH 7.4. The polymer Nafion was deposited on the sites by rapid dip-coating of the 
probe tips in the Nafion solution and oven-casting at 180 °C for 4 min, followed by 4 min cooling in 
ambient air. This process was repeated 3 times. After the polymer treatments, enzyme immobilization 
was accomplished by chemical crosslinking using a solution consisting of GluOx (2 wt%), BSA (2 
wt%) and glutaraldehyde (0.125%). A ~1 µL drop of the solution was formed on a syringe tip and 
fixed in place under a microscope. The probe was attached to a micromanipulator (Sutter Instruments) 
and positioned vertically relative to the enzyme solution droplet. With the aid of the microscope, the 
MEA was lowered into the enzyme droplet to either coat only the bottom 2, or all 4, electrodes. This 
was repeated 4 times with each application consisting of 2-3 dips. MEAs coated with PPy/Nafion and 
d)
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SiO2
c)
Through-wafer etch
e)
Thermal oxide
a)
b)
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B
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GluOx are referred to as MEA glutamate biosensors. The MEAs were sealed in a container with 
desiccant and stored at 4°C. 
 
2.4. Electrode Characterization and Data Analysis  
 
MEA biosensors prepared for glutamate detection were calibrated in vitro to test for sensitivity, 
selectivity and response time to glutamate. In vitro testing was carried out using constant potential 
amperometry with the FAST-16 electrochemistry system. A constant potential of 0.7 V was applied to 
the working electrodes against a Ag/AgCl reference electrode in 40 mL of stirred PBS at pH 7.4 and 
37 ºC within a Faraday cage. Data were collected at 80 kHz and averaged over 1 s intervals. After the 
current detected at the electrodes equilibrated to baseline (approx. 30 min), three 40 µL aliquots of 
glutamate (20 mM) were added to the beaker to reach a final glutamate concentration of 20, 40 and 60 
µM glutamate. Additionally, aliquots of the potential interferents, AA (250µM final concentration) and 
DA (5-10µM final concentration), were added to the beaker in most tests to determine selectivity for 
glutamate. In some cases, lower concentrations of glutamate were added to the beaker (5-10 µM final 
concentration) to more accurately determine glutamate sensitivity. A calibration factor based on 
analysis of these data was calculated for each electrode on the MEAs to be used for in vivo 
experiments. In order to assess the sensitivity and response time to peroxide at sites uncoated with 
enzyme aliquots of H2O2 were also added to the beaker.  
Estimations of MEA response time to glutamate were also made in vitro using a custom-made flow 
cell chamber modeled after Lu et al. [21]. The MEA was lowered into the plexiglass chamber such that 
the tip of the probe entered a narrow channel (2 mm diameter  5 mm depth) through which PBS 
entered the chamber from below. Using a 60 mL syringe driven by a syringe pump, PBS was infused 
through the channel at a rate of 4 mL/min. For these experiments, a potential of 0.7 V versus Ag/AgCl 
was applied across the electrodes, data were collected at 80 kHz and averaged over 0.1 s intervals. A 1 
mL sample loop filled with the analyte of interest (glutamate or H2O2) was used to inject the analyte 
into the chamber over a 10-15 s period. A computer-directed pneumatic actuator controlled the 
switching of the sample injector, and the entire setup was housed in an incubator to maintain the 
temperature at 37 ºC. Concentrations of glutamate and H2O2 ranging from 10-100 µM were used to 
determine MEA response time. Additionally the flow cell apparatus was used to confirm lack of DA 
interference at higher concentrations (20 µM). The FAST-16 system allowed precise marking of the 
event time for each sample injection. Data were output as current as a function of time and analyzed in 
Microsoft Excel. The response time for H2O2 detection at bare platinum sites was used as an estimate 
of the dead time in the system and subtracted from all measurements of response time at coated sites.  
 
2.5. In Vivo Electrode Characterization and Data Analysis 
 
The MEA glutamate biosensors were tested in 2 in vivo applications. Male Sprague Dawely rats 
(Charles River) were individually housed on a 12:12 light/dark cycle with ad libitum access to food 
and water. All experimental procedures and surgeries were conducted in accordance with the 
Institutional Animal Care and Use Committee and UCLA. Standard stereotaxic surgical techniques 
under halothane anesthesia were used to unilaterally implant a microbiosensor, pre-calibrated to 
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glutamate (see above) into the nucleus accumbens core (NAc) of the ventral striatum (VS) using the 
following coordinates according to the atlas of Paxinos and Watson (4th ed.) (AP: +1.7, ML: -1.5, V -
6.0) Additionally, a bipolar stimulating electrode (Plastics One, Roanoke, VA) was unilaterally 
implanted into medial prefrontal cortex (mPFC) (AP: +3.2, ML: -0.8, V -4.4). A 200 µm diameter 
Ag/AgCl reference electrode was implanted contralaterally. The entire experiment was conducted 
inside a Faraday cage. The biosensor was connected to the FAST-16 potentiostat and a potential of 0.7 
V versus Ag/AgCl was applied. Amperometric data were collected at 80 kHz and averaged over 0.1 s 
intervals. The electrode signal was allowed to equilibrate to baseline for approximately 30 min prior to 
application of 0.5 s stimulation trains of 1 ms duration 500-800 µA biphasic square wave pulses at 500 
Hz (Coulbourn Instruments, Whitehall, PA) to the mPFC to elicit current changes detected in the VS at 
the PPy/Nafion/GluOx-coated electrode. Stimulations were administered 30 s apart. Using the 
Quanteon FAST-16 recording system, a record of the precise timing of the stimulation was included 
with the electrochemical dataset. An in vitro calibration factor was used to convert current changes 
detected at the electrode into glutamate concentration changes (see above). In addition to analysis of 
the maximal glutamate concentration change induced by each stimulation train, the temporal dynamics 
of the stimulation-induced glutamate spike were also analyzed (time to peak response and decay time).  
For recording in the awake, freely moving animal connection wires from the MEA and reference 
electrodes were soldered to gold-plated sockets (Ginder Scientific) and the silicon wafer-based MEA 
was attached with epoxy to a 9-pin miniature connector (Ginder Scientific) such that all the sockets 
were encased in the connector. The entire assembly was sealed with epoxy to ensure full insulation and 
allowed to dry for 1 h prior to implantation. A sensor packaged for freely moving animal experiments 
is shown in Figure 2C. The two-electrode MEA biosensor, prepared for glutamate detection and pre-
calibrated, was unilaterally implanted, along with a contralateral 200 µm-diameter Ag/AgCl reference 
electrode, into the rat dorsal striatum (AP: +0.7, ML: +2.4, V -7.0) under halothane anesthesia. The 
connection assembly was anchored to the skull with three stainless steel skull screws along with dental 
acrylic cement (Bosworth Trim, Stokie, IL). A 48 h recovery period preceded onset of recordings.  
Freely moving recordings were conducted in a plexiglass operant chamber (Med Associates, East 
Fairfield, VT) housed within a sound- and light-resistant shell within a Faraday cage. The recording 
headstage (Quanteon) consisted of a round miniature connector with 5 connector pins corresponding to 
the connector housing the implanted biosensor and reference lead. The headstage was tethered to a low 
torque 12 lead commutator (Airflyte, Bayonne, NJ) mounted on the top of the chamber. Outside of the 
operant chamber the commutator connected to the FAST-16 potentiostat. This apparatus allowed the 
animal unrestricted movement within the operant chamber. At test, the headstage was connected to the 
implanted MEA biosensor in the awake animal and a potential of 0.7 V versus Ag/AgCl was applied. 
Amperometric data were collected at 80 kHz and averaged over 1 s intervals. The sensor was allowed 
to equilibrate to baseline for 1 h before experimentation began. After baseline current was attained, the 
sampling average was lowered to 0.5 s for the majority of the experiment. Mild 1 s tail pinches were 
administered using stainless steel forceps. All data were plotted as current versus time (GraphPad 
Prism) and the in vitro calibration factor was used to convert current changes to glutamate 
concentration changes.  
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3. Results and Discussion  
 
3.1. Silicon Wafer-Based Platinum Microelectrode Array Glutamate Biosensors 
 
Figure 2 represents the output of the micromachining process. Each 4 inch silicon wafer (Figure 
2A) houses 150 MEA probes of varying designs. Figure 2E shows a scanning electron microscope 
(SEM) image of the MEA tip of a single probe. The probe shafts are 150 µm thick and 120 µm wide. 
The electrode sites are oval in shape with an approximate width of 40 µm, a length of 100 µm, and a 
surface area of approximately 4,800 µm2. Horizontally paired electrodes are positioned 40 µm apart, 
with the vertical distance between pairs at 100 µm. Figure 2B shows three probes of varying shaft 
lengths (2 mm, 6 mm, 9 mm), designed to reach any part of the rat or mouse brain. Figure 2C shows a 
probe packaged for implantation into the rat brain for awake, freely moving experiments.  
 
Figure 2. Fabricated silicon wafer-based MEA probes. (a) Single 4 in Si wafer with 150 
probes. (b) Released probes of 3 shaft lengths. (c) MEA probe packaged for in vivo 
application. (d) tip of MEA probe showing the 4 pt electrodes (e) SEM image showing 
MEA probe tip. 
 
Our silicon wafer-based MEA probes are inexpensive to produce and can be fabricated in large 
quantities with high reproducibility and yield. These MEA probes have superior mechanical strength 
and are able to withstand implantation into the rodent brain through the dura mater. The probe shaft 
insulation is robust both in vitro and in vivo. Of note, the size and shape of each electrode on the MEA 
as well as the dimensions of the MEA shaft tip itself make these probes ideal for implantation and 
recording specifically from small regions of the rodent brain such as the NAc. Such specific spatial 
resolution is necessary for understanding how changes in glutamate may underlie specific behaviors, 
as activity in adjacent brain regions has been shown to control opposing and dissociable aspects of 
behavior [22]. The design of our probes is also readily altered based on feedback from in vivo 
experiments. Additionally, the 4 site MEA allows the opportunity for multiple recordings of glutamate 
from adjacent parts of a given brain region, collection of data from uncoated sites to control for 
potential changes in endogenous peroxide or, in the future, simultaneous recording of multiple 
neurotransmitters.  
A B
C
D E
Oxide Insulation
Si Substrate
Pt Electrode
150 µm
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The PPy/Nafion/GluOx-coated electrode is able to amperometrically detect glutamate without 
interference from AA and DA (Figure 3). GluOx catalyzes the oxidation of glutamate to α-
ketaglutarate and H2O2 [14]. The PPy and Nafion layers act as size and charge exclusion membranes, 
blocking common interferents present in the extracellular fluid, while allowing small hydrogen 
peroxide molecules to permeate to the electrode surface where an anodic potential is applied [23, 24]. 
The resulting H2O2 oxidation current is proportional to the concentration of glutamate present near the 
electrode surface, thereby acting as the signal output of the sensor. 
 
Figure 3. Schematic representation of the coatings on a single electrode on the MEA. 
 
3.2. Sensitive, Selective and Rapid Detection of Glutamate In Vitro 
 
In vitro tests demonstrated that the MEA biosensors coated with PPy/Nafion/GluOx were sensitive 
to and selective for glutamate in vitro. As shown in Figure 4, additions of increasing concentrations of 
glutamate produced corresponding (Figures 4A, B, C) and linear (Figure 4F) increases in current such 
that the sensitivity to glutamate was 2.46 +/- 0.48 pA/µM, and the limit of glutamate detection was 
0.79 +/- 0.16 µM (11 electrodes on 5 probes) at twice the level of the noise. Given the oxygen-
dependent sensing mechanism employed, this linear glutamate calibration curve cannot be assumed 
accurate for all conditions in vivo, especially at very low oxygen concentrations associated with 
ischemia. Nonetheless, these data, along with work from McMahon and colleagues, indicate these 
sensors are appropriate for detection of small changes in glutamate concentration in vivo under normal 
physiological conditions [25, 26]. Figure 4 also shows the important lack of response to glutamate at a 
site on the same probe coated with PPy/Nafion alone, (Figure 4 A, B, C), despite this site being 
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sensitive to H2O2 (Figure 4 D). The response to glutamate was rapid; the average time to reach 90% of 
the maximal current induced by application of glutamate in the flow cell apparatus at electrodes coated 
with PPy/Nafion/GluOx was 0.8 +/- 0.2 s, (corrected for dead time, 8 electrode sites on 4 probes). This 
response time is comparable to our previously reported over-oxidized PPy coated sensors [13, 24] and 
is also similar to the response time to H2O2 on PPy/Nafion-coated sites devoid of enzyme.  
 
Figure 4. (a-d) Representative flow cell calibration data from a MEA coated with 
PPy/Nafion/GluOx on two electrodes and PPy/Nafion alone on one electrode plotted as 
current versus time. (Calibration timescale corrected for flow cell dead time). (e) 
Sequential addition of AA (250µM), glutamate (20 µM), DA (5 µM) and H2O2 (20 µM) in 
stirred solution. (f) Linear in vitro current v glutamate concentration relationship. 
 
Sensors 2008, 8              
 
 
5032
Electroactive interference, in particular from AA and electroactive cations such as DA in the brain, 
has been a major problem in development of electro-oxidative detection methods for glutamate. 
Importantly, therefore, PPy/Nafion/GluOx-coated platinum electrodes on the MEA probes were found 
to be insensitive to interference from DA and AA in vitro. Application of 250 µM AA and 5-20 µM 
DA failed to produce current responses greater than the noise (Figure 4E). Additional tests 
demonstrated the stability of the interferent exclusion in storage for up to one week after preparation 
(data not shown), but we routinely implant MEAs within one day of coating and on the same day as 
calibration. The degree of selectivity for glutamate at our sensors matches that which we previously 
reported for over-oxidized PPy (without Nafion) on both wire electrodes [13] and ceramic MEAs [24]. 
However, the combined use of (non-over-oxidized) PPy and Nafion on the current MEAs improved the 
success rate of obtaining suitably selective sensors without compromising response time.  
 
3.3. In Vivo Cortical Stimulation-Evoked Glutamate Release in the Ventral Striatum  
 
The silicon wafer-based MEA glutamate biosensors allow for reliable and near real-time recording 
of glutamate release in the VS elicited by afferent stimulation of the mPFC (Figure 5). Stimulus trains 
of 0.5 s in duration (700 µA, 500 Hz) produced an initial current response corresponding to a 326.7 
µM glutamate concentration change, which diminished in amplitude approximately 45% with 
successive stimulations administered 30 s apart, presumably reflecting the depletion of the readily 
releasable pool of glutamate, supporting the physiological nature of the response.  
 
Figure 5. Representative current versus time data showing cortical stimulation evoked 
current changes corresponding to glutamate concentration changes in the NAc of an 
anesthetized rat. Each arrow shows the time of 700 µA, 500 Hz 0.5s stimulation delivery. 
A calibration bar is shown on the right.  
The concentration changes reported are approximate and uncorrected for differences between 
diffusion of glutamate in vivo and in solution, potential degradation of sensor activity in vivo, and 
possible chemical cross-talk between electrode sites due to H2O2 diffusion. Future studies are required 
to determine the minimum separation distance between electrode sites to avoid such potential cross-
talk. These signals reached 80% of their maximum amplitude within 0.8 s and attained maximal 
current within 1.3 s. The decay time back to 30% of baseline occurred within 3.5 s. No current 
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response was detected after even the highest stimulation at a subsequently implanted electrode coated 
with PPy/Nafion but devoid of GluOx in the same location of the same rat, further verifying that the 
response detected at the PPy/Nafion/GluOx electrode was indeed the result of glutamate concentration 
changes (data not shown). 
These data show the novel ability of our silicon wafer-based MEA glutamate biosensors to detect in 
near real-time cortically-evoked glutamate release in the NAc of anesthetized rats. Given that the 
release was detected after neuronal stimulation, it is likely that at least in part our glutamate signal was 
the result of neuronal glutamate release. Similar stimulated glutamate release has been detected in the 
VS of freely moving rats using microdialysis [27], but poor temporal resolution of that technique did 
not offer information on the release dynamics afforded in the current data by the near real-time 
detection of our biosensors. This study did however provide evidence of the significance of mPFC-
driven accumbal glutamate in reward related behavior [27]. Indeed, changes in glutamate release in the 
VS have been shown to be necessary for both cocaine and heroin seeking behavior [28, 29]. These data 
provide strong evidence for the utility of these glutamate biosensors for assessing, in specific brain 
regions, the glutamatergic component of reward related behavior.  
 
3.4. Stress-Induced Striatal Glutamate Release in Awake Freely Moving Rat 
 
As an initial step to demonstrate the utility of these sensors to detect behaviorally relevant rapid 
glutamate concentration changes in the freely moving rat, a 1 s tail pinch was used as a mild stressor to 
induce glutamate release in the dorsal striatum. Figure 6 shows representative responses at two 
PPy/Nafion/GluOx-coated electrode sites of an MEA implanted in the dorsal striatum.  
 
Figure 6. Stress-induced current changes corresponding to glutamate release in the dorsal 
striatum of a freely-moving rat. Arrows indicate each mild 1 s tail pinch.  
Each tail pinch evoked an immediate increase in the current corresponding to glutamate 
concentration changes of 2.9 µM and 4.9 µM at the two electrode sites. Not surprisingly, these are 
much smaller responses than produced by the high intensity, high frequency stimulation described 
above but, similar to the electrical stimulation data, subsequent tail pinches resulted in approximately a 
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40% decrease in the glutamate concentration change, in this case perhaps reflecting desensitization of 
the stress response. Pinch-induced spikes reached on average a maximum current within 1.5 s and 
decayed to 30% of baseline within 2-3 s of maximal response (Figure 6).  
In addition to showing a role for striatal glutamate release in mild stress, these data clearly show the 
utility of our silicon wafer-based MEA glutamate biosensors for detecting behaviorally relevant rapid 
glutamate concentration changes in the freely moving animal. Others have reported similar tail-pinch 
induced glutamate concentration changes of approximately 0.5 µM detected at platinum wire-based 
glutamate biosensors in the ambulant animal [12]. The current data show increased responsiveness as 
here a 1 s tail pinch induced a larger increase in glutamate than the 10 s stimulus used in the previous 
study. This could be due to a number of variables but one factor could be the discrete nature of the 
recording sites on the MEA relative to the large surface area of the wire electrodes, the latter 
potentially resulting in averaging out of large spatially resolved changes in extracellular glutamate 
concentration. Previous work has also shown 5 min tail-pinch induced glutamate release detected on 
ceramic MEA glutamate biosensors [30]. Indeed, this work shows a more robust glutamate response to 
this much more robust stressor [30]. The current result provides evidence of the capability of our 
silicon wafer-based MEA glutamate biosensors to detect relatively minor stress-induced glutamate 
release in the striatum of the ambulant rat, indicating their potential ability to detect subtle changes in 
glutamate concentration associated with specific behaviors. 
 
4. Conclusions  
 
We report a novel silicon wafer-based MEA glutamate biosensor created with MEMS technologies 
for sensitive, selective, temporally and spatially precise measurement of glutamate in vivo. 
PPy/Nafion/GluOx coatings provided effective rejection of the electroactive interferents, AA and DA, 
along with rapid and sensitive glutamate detection both in vitro and in vivo. The utility of these sensors 
for measuring electrical stimulation- and behaviorally-evoked glutamate release in vivo was 
established.  
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